Search - tctmd.com

Displaying 941 - 960 of 2033

Sort: Relevancy | Date

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

Yael L. Maxwell

March 23, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

Todd Neale

March 22, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Todd Neale

March 06, 2017

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

L.A. McKeown

March 02, 2017

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Daily News

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Shelley Wood

February 23, 2017

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Industry News

Micro Medical Solutions Receives CE Mark Approval for MicroStent

February 14, 2017

News Daily News

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

Yael L. Maxwell

February 13, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Industry News

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

February 07, 2017

News Daily News

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Michael O'Riordan

February 07, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

Advertisement

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them

FDA Approves Next-Gen CoreValve Evolut PRO Valve

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Micro Medical Solutions Receives CE Mark Approval for MicroStent

AHA Wades Into Conversation Over Periprocedural Use of Non-Vitamin K Antagonist Oral Anticoagulants

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content